In other words, mean CTNNB1 mRNA expression was lower in the tumour subset with high CDKN1A expression than in the tumour subset with low CDKN1A expression, which was consistent with β-catenin having an inhibitory effect on CDKN1A mRNA expression. Here, CTNNB1 is linked to neoplasm.